Loading...
Cellular androgen content influences enzalutamide agonism of F877L mutant androgen receptor
Prostate cancer is the most commonly diagnosed and second-most lethal cancer among men in the United States. The vast majority of prostate cancer deaths are due to castration-resistant prostate cancer (CRPC) – the lethal form of the disease that has progressed despite therapies that interfere with a...
Na minha lista:
| Udgivet i: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals LLC
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5130036/ https://ncbi.nlm.nih.gov/pubmed/27276681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9816 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|